CRISPR-targeting removed 89 bp spanning exon 15 and intron 16 that removes the critical catalytic residues (NPPF) from the methyltransferase domain and creates a premature termination codon. Western blot analysis confirmed the absence of protein expression in several tissues. (J:293136)